ApoA1 (Apolipoprotein A1) is synthesized in the liver and small intestine, and is the major protein component of high density lipoprotein (HDL) in the plasma. ApoA1 has a unique ability to capture and solubilize free cholesterol, and promotes cholesterol efflux from tissues to the liver for excretion. The process, called reverse cholesterol transport, is thought to inhibit atherogenesis. The recombinant human ApoA1 consists of 244 amino acids and predicts a molecular mass of 28.2 KD
Description: Applications:
Source: Human Expression System: E. coli Tag: N-terminal His-tag Purity: >95% as determined by SDS-PAGE Endotoxin Level: Less than 0.1EU/ug by LAL method Recommended Storage Condition: -20°C Expiration date: 12 months |
| There is no documents for this product.Will be available soon. |
| The Q&A for this product will be available soon. |
|
|
|
|
| Customized Competent E. coli | BL21(DE3) Competent E. coli | HB101 Competent E. coli |
|
$550.00
|
$110.00
|
$110.00
|
|
|
|
|
| Lyse-load solution (5x1ml) | T4 Endonuclease VII | BL21(DE3)pLysS Competent E. coli |
|
$95.00
|
$200.00
|
$110.00
|
|
|
|
| Dh5-Alpha Competent E. coli | Taq DNA Polymerase | Brij-35 (30% Solution) |
|
$110.00
|
$100.00
|
$66.00
|
